HF
STRO icon

HRT Financial’s Sutro Biopharma STRO Stock Holding History

HRT Financial’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,551
Closed -$61K – 3636
2025
Q2 		$61K Buy
8,551
+5,873
+219% +$48K ﹤0.01% 2283
2025
Q1 		$17K Buy
+2,678
New +$42.2K ﹤0.01% 2316
2024
Q2 		– Sell
-1,206
Closed -$68K – 3062
2024
Q1 		$68K Buy
+1,206
New +$53.3K ﹤0.01% 1903
2022
Q3 		– Sell
-16,201
Closed -$844K – 3479
2022
Q2 		$844K Buy
+16,201
New +$905K 0.01% 1062
2022
Q1 		– Sell
-3,938
Closed -$585K – 3827
2021
Q4 		$585K Buy
+3,938
New +$705K ﹤0.01% 1636

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

HRT Financial's STRO Position: Q3 2025 in Review

HRT Financial sold out of Sutro Biopharma (STRO) in Q3 2025, closing a stake of 8,551 shares — an estimated $61K sold.

HRT Financial first reported a position in STRO in Q4 2021 and held it in 5 quarters. The position peaked at $844K in Q2 2022. 87 funds tracked by Wall St. Rank hold STRO as of Q3 2025.

  • HRT Financial reported no remaining Sutro Biopharma position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 8,551 Sutro Biopharma shares in Q3 2025, an estimated $61K.
  • HRT Financial first reported a position in Sutro Biopharma in Q4 2021 and held it in 5 quarters.
  • HRT Financial's Sutro Biopharma position peaked at $844K in Q2 2022.
  • 87 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.